Hims & Hers Health

Hims & Hers Health is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling access to high-quality medical care for conditions related to mental health, sexual health, dermatology, haircare, and more.

CCI Score

-38.75

0.02% April 18

Latest Event

Hims & Hers Expands Weight-Loss Medications and Advocates for Access

On April 1, 2025, Hims & Hers Health announced the addition of new weight-loss medications including Zepbound, Mounjaro, and liraglutide to its telehealth platform. In tandem with this expansion, the company is lobbying for the preservation of access to compounded treatments, urging Congress and the FDA to maintain availability for patients. This move underscores the company's engagement in political processes aimed at protecting consumer health and ensuring democratic participation.

Take Action

So what can you do? It's time to make tough choices. Where will you cast your vote?

Shop Alternatives SEE ALL: Northwestern Medicine

Intermountain Health

NHS
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

TOADIE

Hims & Hers Health is currently rated as a Toadie.

-30 to -44 CCI Score

Companies scoring in this range actively seek to please authoritarian regimes. They offer proactive support and assistance in exchange for preferential treatment, compromising ethical standards for business gains and political favor.

Latest Events

APR

01

2025

Hims & Hers Expands Weight-Loss Medications and Advocates for Access
50.00

On April 1, 2025, Hims & Hers Health announced the addition of new weight-loss medications including Zepbound, Mounjaro, and liraglutide to its telehealth platform. In tandem with this expansion, the company is lobbying for the preservation of access to compounded treatments, urging Congress and the FDA to maintain availability for patients. This move underscores the company's engagement in political processes aimed at protecting consumer health and ensuring democratic participation.
FEB

20

2025

Controversial Super Bowl Ad and FDA Regulatory Compliance Issues
-38.48

Hims & Hers Health aired a Super Bowl commercial that faced criticism for insufficiently disclosing the lack of FDA approval for its compounded weight loss drugs. The ad's misleading presentation has raised ethical concerns and prompted bipartisan regulatory scrutiny.
-30

Public and Political Behavior

March 24

The advertisement generated significant political backlash, drawing criticism from U.S. Senators and regulators, and raises questions about Hims & Hers' approach to public messaging and accountability. The company's handling of regulatory information in a high-profile setting indicates problematic public and political behavior.

Hims & Hers Super Bowl Ad Raises Controversy Over FDA Regulatory Compliance
-50

Business Practices and Ethical Responsibility

March 24

The ad's inadequate disclaimer about the use of compounded, non-FDA approved drugs reflects a disregard for ethical advertising practices. This omission misleads consumers about drug safety and regulatory compliance, highlighting deficient business practices and ethical responsibility.

Hims & Hers Super Bowl Ad Raises Controversy Over FDA Regulatory Compliance
FEB

11

2025

Hims & Hers Health Lobbying Activity
-29.46

Hims & Hers Health is identified as a lobbying client with documented political engagement from May 2024 to April 2025, suggesting corporate influence in political processes that may contribute to authoritarian practices.
-30

Political Contributions and Lobbying Efforts

March 24

Evidence from VPAP indicates that Hims & Hers Health is a registered lobbying client with activity noted between May 2024 and April 2025. This engagement raises concerns about the company's role in influencing political decisions and potentially supporting authoritarian policies by leveraging its corporate power in political spheres.

Hims & Hers Health Inc. (Lobbying Client)
FEB

06

2025

Hims & Hers FDA Scrutiny Over Super Bowl Ad
-49.04

The Hims & Hers Super Bowl advertisement has drawn regulatory attention from the FDA over potentially misleading health marketing practices, raising concerns about the company's transparency and ethical responsibility in promoting its telehealth services.
-50

Business Practices and Ethical Responsibility

March 24

Hims & Hers Health faced regulatory scrutiny over its Super Bowl ad, which has been criticized for potentially making misleading health claims. This controversy highlights issues in business practices and ethical responsibility, particularly in how the company markets its telehealth products. The FDA’s attention underscores concerns about transparency and accuracy in health-related communications, which can erode consumer trust and contribute indirectly to broader systemic issues of corporate accountability.

Unpacking the Controversy: Hims & Hers Super Bowl Ad Under FDA Scrutiny
JAN

07

2025

Hims & Hers Health Political Donation to Trump's Inaugural Fund
-48.64

Hims & Hers Health’s $1 million donation to President-elect Trump’s inaugural fund illustrates a troubling alignment with authoritarian political interests. This financial contribution appears designed to curry favor with influential policymakers, potentially undermining the integrity of public health policy for corporate gain.
-50

Political Contributions and Lobbying Efforts

March 24

Hims & Hers Health’s decision to donate $1 million to President-elect Trump’s inaugural fund represents a clear example of political contributions that may be used to secure preferential treatment in regulatory and policy arenas. Such actions raise serious concerns about corporate complicity in promoting an authoritarian agenda, aligning business interests with far-right political currents rather than prioritizing public ethical responsibility.

The Intersection of Health Tech Donations and Political Influence: A Critical Examination
JAN

07

2025

Hims & Hers Health Donation Sparks Political Influence Concerns
-77.82

Hims & Hers Health donated $1M to President Trump's inauguration fund, a move that aligns the company with an authoritarian political agenda and raises concerns about its influence on public health policy through political contributions.
-80

Political Contributions and Lobbying Efforts

March 24

Hims & Hers Health's $1M donation to President Trump's inauguration fund is a significant indicator of the company engaging in political contributions that favor an authoritarian regime. This act not only seeks to curry favor with policymakers but also risks prioritizing corporate interests over the public good in healthcare regulation, thereby contributing to environments that support fascist tendencies.

Analyzing Corporate Influence in Politics: The Case of Hims & Hers Health
JAN

07

2025

Hims & Hers Health Donation to Trump's Inaugural Committee
-77.80

Hims & Hers Health donated $1 million to President-elect Donald Trump's inaugural committee, marking a significant political contribution. This donation signals alignment with an authoritarian political agenda, potentially aiding policies that undermine democratic norms.
-80

Public and Political Behavior

March 24

The donation of $1 million by Hims & Hers Health to Trump's inaugural committee is viewed negatively from an anti-fascist perspective, as it supports a political figure associated with authoritarian tendencies. This act of political contribution could be seen as facilitating an agenda that undermines democratic principles and promotes authoritarian influence.

Hims donates to Trump's inaugural committee - Axios